Published in Law and Health Weekly, July 16th, 2005
Recordati will continue the development of the drug for their assigned territory. While the specific terms of the agreement were not revealed, it was disclosed that Recordati will make certain milestone payments to InfaCare during...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly